ethidium has been researched along with kn 62 in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 10 (83.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cornish, JE; Gargett, CE; Wiley, JS | 1 |
| Dubyak, GR; Humphreys, BD; Rice, J; Surprenant, A; Virginio, C | 1 |
| Hibell, AD; Humphrey, PP; Michel, AD; Thompson, KM; Xing, M | 1 |
| Baraldi, PG; del Carmen Nuñez, M; Di Virgilio, F; Falzoni, S; Morelli, A; Romagnoli, R | 1 |
| Adinolfi, E; Baricordi, R; Di Virgilio, F; Falzoni, S; Ferrari, D; Forchap, S; Minelli, M; Pizzirani, C; Sitta, B; Turchet, L | 1 |
| Christopherson, RI; Fuller, SJ; Georgiou, JG; Martin, CJ; Skarratt, KK; Sluyter, R; Wiley, JS | 1 |
| Baraldi, PG; Borea, PA; Cara, CL; Carrion, MD; Cruz-Lopez, O; Fogli, E; Gessi, S; Moorman, AR; Preti, D; Romagnoli, R; Sacchetto, V; Tabrizi, MA | 1 |
| Fuller, SJ; Georgiou, JG; Gu, BJ; Jursik, C; Sluyter, R; Wiley, JS | 1 |
| Dehaye, JP; Garcia-Marcos, M; Marino, A; Otto, A; Pochet, S; Seil, M | 1 |
| Chambers, LJ; Michel, AD; Walter, DS | 1 |
| Di Virgilio, F; Gulinelli, S; Pellegatti, P; Pizzirani, C; Skerlavaj, B; Tomasinsig, L; Tossi, A; Zanetti, M | 1 |
| Kim, JH; Kim, WK; Kim, YC; Lee, GE; Lee, HS; Lee, SD | 1 |
12 other study(ies) available for ethidium and kn 62
| Article | Year |
|---|---|
ATP, a partial agonist for the P2Z receptor of human lymphocytes.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenosine Triphosphate; Affinity Labels; Barium; Dose-Response Relationship, Drug; Enzyme Inhibitors; Ethidium; Flow Cytometry; Humans; In Vitro Techniques; Ion Channels; Leukemia, Lymphocytic, Chronic, B-Cell; Linear Models; Lymphocytes; Purinergic P2 Receptor Agonists; Receptors, Purinergic P2; Receptors, Purinergic P2X7; Structure-Activity Relationship; Thionucleotides | 1997 |
Isoquinolines as antagonists of the P2X7 nucleotide receptor: high selectivity for the human versus rat receptor homologues.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenosine Triphosphate; Animals; Cells, Cultured; Chimera; Enzyme Inhibitors; Ethidium; Fluorescent Dyes; Humans; Ion Transport; Isoquinolines; Leukocytes; Purinergic P2 Receptor Antagonists; Rats; Receptors, Purinergic P2; Receptors, Purinergic P2X7 | 1998 |
Complexities of measuring antagonist potency at P2X(7) receptor orthologs.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenosine Triphosphate; Amiloride; Animals; Benzoxazoles; Buffers; Cations, Divalent; Cell Adhesion; Cells, Cultured; Drug Interactions; Enzyme Inhibitors; Ethidium; Fluorescent Dyes; Humans; Kinetics; Mice; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Quinolinium Compounds; Rats; Receptors, Purinergic P2; Receptors, Purinergic P2X7; Rosaniline Dyes; Serum Albumin, Bovine; Sodium Chloride; Species Specificity; Temperature | 2001 |
Synthesis and biological activity of N-arylpiperazine-modified analogues of KN-62, a potent antagonist of the purinergic P2X7 receptor.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenosine Triphosphate; Arylsulfonates; Calcium; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium-Calmodulin-Dependent Protein Kinases; Cells, Cultured; Ethidium; Humans; Interleukin-1; Macrophages; Monocytes; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2X7; Structure-Activity Relationship; Tyrosine | 2003 |
The antibiotic polymyxin B modulates P2X7 receptor function.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenosine Triphosphate; Amino Acid Sequence; Animals; Anti-Bacterial Agents; Calcium; Cell Line; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Ethidium; Humans; Intracellular Fluid; K562 Cells; Leukemia, Lymphocytic, Chronic, B-Cell; Macrophages; Mice; Molecular Sequence Data; Oxidation-Reduction; Polymyxin B; Purinergic P2 Receptor Antagonists; Rats; Receptors, Purinergic P2; Receptors, Purinergic P2X7; Transfection | 2004 |
Human epidermal and monocyte-derived langerhans cells express functional P2X receptors.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenosine Triphosphate; Biological Transport; Epidermal Cells; Ethidium; Humans; Keratinocytes; Langerhans Cells; Monocytes; Polymorphism, Genetic; Receptors, IgE; Receptors, Purinergic P2; Receptors, Purinergic P2X7; Skin | 2005 |
From tyrosine to glycine: synthesis and biological activity of potent antagonists of the purinergic P2X7 receptor.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenosine Triphosphate; beta-Alanine; Calcium; Cell Line; Cell Membrane; Cell Membrane Permeability; Ethidium; Fluorescent Dyes; Glycine; Humans; Isoquinolines; Naphthalenes; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2X7; Recombinant Proteins; Structure-Activity Relationship; Sulfonamides; Sulfones; Tyrosine | 2007 |
A quantitative method for routine measurement of cell surface P2X7 receptor function in leucocyte subsets by two-colour time-resolved flow cytometry.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenosine Triphosphate; B-Lymphocytes; Barium; Biological Transport; Calcium; Chlorides; Enzyme Inhibitors; Ethidium; Flow Cytometry; Humans; Killer Cells, Natural; Leukocytes, Mononuclear; Monocytes; Potassium; Receptors, Purinergic P2; Receptors, Purinergic P2X7; Reproducibility of Results; Sodium; T-Lymphocytes; Temperature | 2007 |
Contribution of two ionotropic purinergic receptors to ATP responses in submandibular gland ductal cells.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenosine Triphosphate; Animals; Biological Transport; Calcium; Carbachol; Ethidium; Interleukin-1beta; Mice; Mice, Knockout; Phospholipases A2; Receptors, Purinergic P2; Receptors, Purinergic P2X4; Receptors, Purinergic P2X7; Saliva; Submandibular Gland | 2007 |
Negative and positive allosteric modulators of the P2X(7) receptor.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenosine Triphosphate; Allosteric Regulation; Animals; Binding Sites; Cell Line; Dose-Response Relationship, Drug; Ethidium; Glycine; Humans; Molecular Structure; Piperazines; Protein Conformation; Pyridoxal Phosphate; Quinolines; Radioligand Assay; Rats; Receptors, Purinergic P2; Receptors, Purinergic P2X7; Recombinant Proteins; Species Specificity; Time Factors; Transfection; Vanadates | 2008 |
The human cathelicidin LL-37 modulates the activities of the P2X7 receptor in a structure-dependent manner.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenosine Triphosphate; Animals; Antimicrobial Cationic Peptides; Calcium; Calcium Signaling; Cathelicidins; Cell Proliferation; Enzyme Inhibitors; Ethidium; Fibroblasts; Gene Expression Regulation; Humans; Mice; NIH 3T3 Cells; Protein Structure, Secondary; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2X7; Structure-Activity Relationship | 2008 |
Synthesis and structure-activity relationships of novel, substituted 5,6-dihydrodibenzo[a,g]quinolizinium P2X7 antagonists.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Alkaloids; Berberine Alkaloids; Cell Differentiation; Cell Line; Chemistry, Pharmaceutical; Drug Design; Ethidium; Humans; Interleukin-1beta; Lipopolysaccharides; Models, Chemical; Purinergic P2 Receptor Antagonists; Quinolizines; Receptors, Purinergic P2X7; Structure-Activity Relationship | 2009 |